GW & Wade’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $7.37M | Sell |
12,639
-790
| -6% | -$461K | 0.24% | 87 |
|
|
2023
Q3 | $7.21M | Buy |
13,429
+3,946
| +42% | +$2.03M | 0.27% | 80 |
|
|
2023
Q2 | $4.45M | Sell |
9,483
-906
| -9% | -$380K | 0.16% | 105 |
|
|
2023
Q1 | $3.57M | Sell |
10,389
-58
| -0.6% | -$19.6K | 0.14% | 115 |
|
|
2022
Q4 | $3.82M | Sell |
10,447
-17
| -0.2% | -$6.03K | 0.16% | 107 |
|
|
2022
Q3 | $3.38M | Sell |
10,464
-166
| -2% | -$52.6K | 0.17% | 102 |
|
|
2022
Q2 | $3.45M | Buy |
10,630
+976
| +10% | +$293K | 0.16% | 103 |
|
|
2022
Q1 | $2.77M | Buy |
9,654
+1,100
| +13% | +$283K | 0.12% | 107 |
|
|
2021
Q4 | $2.36M | Buy |
8,554
+429
| +5% | +$109K | 0.1% | 120 |
|
|
2021
Q3 | $1.88M | Sell |
8,125
-171
| -2% | -$42.2K | 0.09% | 142 |
|
|
2021
Q2 | $1.9M | Sell |
8,296
-1,884
| -19% | -$378K | 0.09% | 137 |
|
|
2021
Q1 | $1.9M | Buy |
10,180
+601
| +6% | +$118K | 0.1% | 121 |
|
|
2020
Q4 | $1.62M | Sell |
9,579
-604
| -6% | -$90.2K | 0.1% | 113 |
|
|
2020
Q3 | $1.51M | Buy |
10,183
+2
| +0% | +$310 | 0.11% | 94 |
|
|
2020
Q2 | $1.67M | Buy |
10,181
+2,293
| +29% | +$352K | 0.14% | 90 |
|
|
2020
Q1 | $1.09M | Sell |
7,888
-438
| -5% | -$60.2K | 0.1% | 102 |
|
|
2019
Q4 | $1.09M | Buy |
8,326
+11
| +0.1% | +$1.27K | 0.08% | 120 |
|
|
2019
Q3 | $930K | Buy |
8,315
+501
| +6% | +$55.8K | 0.08% | 117 |
|
|
2019
Q2 | $866K | Sell |
7,814
-1,616
| -17% | -$190K | 0.08% | 118 |
|
|
2019
Q1 | $1.22M | Buy |
9,430
+1,702
| +22% | +$207K | 0.12% | 106 |
|
|
2018
Q4 | $894K | Sell |
7,728
-92
| -1% | -$10.3K | 0.1% | 113 |
|
|
2018
Q3 | $839K | Buy |
7,820
+8
| +0.1% | +$800 | 0.09% | 119 |
|
|
2018
Q2 | $667K | Buy |
7,812
+9
| +0.1% | +$739 | 0.08% | 130 |
|
|
2018
Q1 | $604K | Buy |
7,803
+1,011
| +15% | +$81.4K | 0.07% | 135 |
|
|
2017
Q4 | $574K | Sell |
6,792
-56
| -0.8% | -$4.76K | 0.07% | 130 |
|
|
2017
Q3 | $586K | Buy |
6,848
+123
| +2% | +$10.1K | 0.07% | 128 |
|
|
2017
Q2 | $553K | Sell |
6,725
-119
| -2% | -$9.71K | 0.07% | 129 |
|
|
2017
Q1 | $576K | Buy |
6,844
+257
| +4% | +$20.6K | 0.08% | 125 |
|
|
2016
Q4 | $484K | Sell |
6,587
-189
| -3% | -$14.1K | 0.08% | 131 |
|
|
2016
Q3 | $544K | Sell |
6,776
-79
| -1% | -$6.32K | 0.1% | 118 |
|
|
2016
Q2 | $540K | Sell |
6,855
-315
| -4% | -$23.7K | 0.09% | 136 |
|
|
2016
Q1 | $516K | Sell |
7,170
-3,394
| -32% | -$257K | 0.1% | 116 |
|
|
2015
Q4 | $890K | Sell |
10,564
-96
| -0.9% | -$7.97K | 0.19% | 92 |
|
|
2015
Q3 | $892K | Sell |
10,660
-1,910
| -15% | -$161K | 0.2% | 89 |
|
|
2015
Q2 | $1.05M | Buy |
12,570
+2
| +0% | +$152 | 0.21% | 92 |
|
|
2015
Q1 | $913K | Buy |
12,568
+8,976
| +250% | +$639K | 0.17% | 102 |
|
|
2014
Q4 | $248K | Buy |
+3,592
| New | +$242K | 0.07% | 116 |
|
Other funds holding LLY
GW & Wade's LLY Position: Q4 2023 in Review
GW & Wade reduced its Eli Lilly (LLY) stake by 5.9% in Q4 2023, selling an estimated $461K and leaving 12,639 shares worth $7.37M. The position accounts for 0.24% of the portfolio, ranked #87.
GW & Wade first reported a position in LLY in Q4 2014 and has held it in 37 quarters since. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.
- GW & Wade held 12,639 shares of Eli Lilly worth $7.37M as of Q4 2023.
- GW & Wade sold 790 Eli Lilly shares in Q4 2023, an estimated $461K.
- Eli Lilly made up 0.24% of GW & Wade's portfolio in Q4 2023, its #87 holding.
- GW & Wade first reported a position in Eli Lilly in Q4 2014 and has held it in 37 quarters since.
- 3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.